is glp 1 considered insulin GLP-1 and GIP in Type Diabetes Therapy: A Time for Reappraisal? The Clinical Application of GLP-1RAs

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinsons disease: mechanisms of action

This type of study combines and analyzes results from multiple previous investigations in this case four observational studies that included nearly 37,000 pregnancies

Why should you give one of the best diets of 2018 a shot

The overall incidence of pre-specified adverse reactions of hypoglycemia in patients with type 2 diabetes inadequately controlled on diet and exercise was 0.6% in patients given placebo, 0.6% in patients given sitagliptin alone, 0.8% in patients given metformin alone, and 1.6% in patients given sitagliptin in combination with metformin

Symptoms of low blood sugar: shakiness, sweating, heart palpitations, confusion, and irritability